IBRUTINIB and PNEUMONIA

Overview

PNEUMONIA is the #6 most commonly reported adverse reaction for IBRUTINIB, manufactured by Pharmacyclics LLC. There are 3,186 FDA adverse event reports linking IBRUTINIB to PNEUMONIA. This represents approximately 2.5% of all 129,122 adverse event reports for this drug.

Patients taking IBRUTINIB who experience pneumonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PNEUMONIA is a less commonly reported adverse event for IBRUTINIB, but still significant enough to appear in the safety profile.

Other Side Effects of IBRUTINIB

In addition to pneumonia, the following adverse reactions have been reported for IBRUTINIB:

• DEATH — 8,367 reports
• OFF LABEL USE — 5,878 reports
• FATIGUE — 4,668 reports
• DIARRHOEA — 4,101 reports
• ATRIAL FIBRILLATION — 3,797 reports
• CONTUSION — 2,778 reports
• INCORRECT DOSE ADMINISTERED — 2,776 reports
• FALL — 2,474 reports
• ASTHENIA — 2,318 reports
• NAUSEA — 2,272 reports

Other Drugs Associated with PNEUMONIA

The following drugs have also been linked to pneumonia in FDA adverse event reports:

Does IBRUTINIB cause PNEUMONIA?

PNEUMONIA has been reported as an adverse event in 3,186 FDA reports for IBRUTINIB. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PNEUMONIA with IBRUTINIB?

PNEUMONIA accounts for approximately 2.5% of all adverse event reports for IBRUTINIB, making it a notable side effect.

What should I do if I experience PNEUMONIA while taking IBRUTINIB?

If you experience pneumonia while taking IBRUTINIB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages